A current example of using ASOs to increase protein levels by skipping a poison exon is for Dravet syndrome, an autosomal dominant disease, which is caused by variants in the SCN1A gene causing reduced expression of voltage-gated sodium channel alpha subunit Nav1.1. This evidence concerns the gene SCN1A and Dravet syndrome.